UK-Estonian healthtech startup Lifeyear raises €2.8M to launch digital cardiovascular care platform

Lifeyear, a UK-Estonian healthtech startup, has raised €2.8 million to launch its remote patient management platform, delivering at-home digital cardiovascular care. The round was baked by deep tech grant funding from the Estonian government and Verge HealthTech Fund, Tilia Impact Ventures, PurposeTech, and Estonian angel investors.

About Lifeyear

• Lifeyear is a UK-based company, founded by Estonians Siim Saare and Timo Mitt, focused on transforming cardiovascular care with next-generation remote patient management. 

• Its smartphone-enabled system helps healthcare providers optimize care delivery, reduce cardiac waitlists, and empower patients to manage their heart health from home. 

• Lifeyear’s solution supports hospitals, clinics, and GP practices by reducing unnecessary visits and readmissions, improving efficiency, and cutting overall care costs. The company merges UK clinical expertise with Estonia’s renowned digital health innovation.

“This funding is a pivotal step in our mission to reduce the global cardiovascular disease burden. With a stellar team and strategic backing from leading investors and clinical excellence centres, we’re focused on redefining how cardiovascular care is delivered, starting with patients who need it the most,” says Siim Saare, Founder and CEO.

Investment details

The round includes €1.5 million in deep tech grant funding from the Estonian government, as well as €1.3 million from venture capital funds, including Verge HealthTech Fund, Tilia Impact Ventures, PurposeTech, and Estonian angel investors.

• Verge HealthTech Fund is a Singapore-based VC firm, specializes in early-stage investments in healthtech startups globally, focusing on technologies that improve healthcare accessibility, quality, and efficiency.

• Tilia Impact Ventures is a Czech venture capital firm focused on investing in and supporting early-stage startups that create positive social and environmental impact.

• PurposeTech, a Prague-based pre-seed fund, supports purpose-driven startups in Central and Eastern Europe, focusing on solutions for global challenges like climate change, healthcare, education, and social justice.

The funding will be used to accelerate the rollout of Lifeyear’s digital cardiac care platform across selected UK hospitals, GP practices, and virtual wards, enabling the team to refine the technology and validate its clinical potential.